88 related articles for article (PubMed ID: 12114885)
1. Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: a randomized controlled study.
Madsen JS; Kristensen SR; Klitgaard NA; Bladbjerg EM; Abrahamsen B; Stilgren L; Jespersen J
Am J Obstet Gynecol; 2002 Jul; 187(1):33-9. PubMed ID: 12114885
[TBL] [Abstract][Full Text] [Related]
2. The C677T methylenetetrahydrofolate reductase polymorphism influences the homocysteine-lowering effect of hormone replacement therapy.
Brown CA; McKinney KQ; Young KB; Norton HJ
Mol Genet Metab; 1999 May; 67(1):43-8. PubMed ID: 10329022
[TBL] [Abstract][Full Text] [Related]
3. Continuous combined hormone replacement therapy with oral 17beta-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women.
Ventura P; Cagnacci A; Malmusi S; Panini R; Baldassari F; Arangino S; Volpe A; Salvioli G
Menopause; 2001; 8(4):252-8. PubMed ID: 11449082
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the effects of sequential transdermal versus continuous orally administered hormone replacement therapies on plasma total homocysteine levels in postmenopausal women: a randomized, placebo-controlled study.
Kurtay G; Ozmen B
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):206-11. PubMed ID: 16814449
[TBL] [Abstract][Full Text] [Related]
5. The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.
D'Anna R; Baviera G; Corrado F; Cancellieri F; Crisafulli A; Squadrito F
Acta Obstet Gynecol Scand; 2005 May; 84(5):474-7. PubMed ID: 15842212
[TBL] [Abstract][Full Text] [Related]
6. Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effect of plasma lipoproteins in a two-year placebo-controlled trial.
Munk-Jensen N; Ulrich LG; Obel EB; Nielsen SP; Edwards D; Meinertz H
Am J Obstet Gynecol; 1994 Jul; 171(1):132-8. PubMed ID: 8030688
[TBL] [Abstract][Full Text] [Related]
7. Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal women.
Madsen JS; Kristensen SR; Gram J; Bladbjerg EM; Henriksen FL; Gram J; Christensen K; Jespersen J
J Thromb Haemost; 2003 Sep; 1(9):1984-91. PubMed ID: 12941041
[TBL] [Abstract][Full Text] [Related]
8. Effects of low-dose 17-beta-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women.
Kaleli B; Yildirim B; Demir S; Alatas E
Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1107-11. PubMed ID: 14616255
[TBL] [Abstract][Full Text] [Related]
9. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G
Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946
[TBL] [Abstract][Full Text] [Related]
10. What is the influence of hormone therapy on homocysteine and crp levels in postmenopausal women?
Lakryc EM; Machado RB; Soares JM; Fernandes CE; Baracat EC
Clinics (Sao Paulo); 2015 Feb; 70(2):107-13. PubMed ID: 25789519
[TBL] [Abstract][Full Text] [Related]
11. Effects of hormone replacement therapy on plasma glutathione S-transferase A1-1 concentrations in healthy postmenopausal women.
Mulder TP; Knapen MF; van der Mooren MJ; Demacker PD; Roes EM; Steegers EA; Peters WH
Clin Chem; 1998 Mar; 44(3):666-7. PubMed ID: 9510879
[No Abstract] [Full Text] [Related]
12. Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine.
Os I; Os A; Sandset PM; Bølling S; Seljeflot I; Djurovic S; Westheim A
Cardiology; 2002; 98(1-2):6-12. PubMed ID: 12373040
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China.
Li Z; Sun L; Zhang H; Liao Y; Wang D; Zhao B; Zhu Z; Zhao J; Ma A; Han Y; Wang Y; Shi Y; Ye J; Hui R;
Stroke; 2003 Sep; 34(9):2085-90. PubMed ID: 12907815
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral hormone replacement therapy on plasma homocysteine levels.
Guimarães DA; Cardoso J; Dusse LM; Franco RM; Franco Hde A; Alvim TC; Teixeira Gda S; Carvalho Md; Fernandes AP
Acta Obstet Gynecol Scand; 2006; 85(11):1304-6. PubMed ID: 17091407
[TBL] [Abstract][Full Text] [Related]
16. [Homocysteinemia and ovariectomy--initial experience with functional monitoring].
Kaprál A; Hyánek J; Zivný J; Pejznochová H; Dubská L; Fait T
Ceska Gynekol; 2002 Nov; 67(6):328-32. PubMed ID: 12661370
[TBL] [Abstract][Full Text] [Related]
17. The effect of postmenopausal hormone therapy with or without folic acid supplementation on serum homocysteine level.
Toprak A; Erenus M; Ilhan AH; Haklar G; Fak AS; Oktay A
Climacteric; 2005 Sep; 8(3):279-86. PubMed ID: 16390760
[TBL] [Abstract][Full Text] [Related]
18. Effect of the methylenetetrahydrofolate reductase 677C-->T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample.
de Bree A; Verschuren WM; Bjørke-Monsen AL; van der Put NM; Heil SG; Trijbels FJ; Blom HJ
Am J Clin Nutr; 2003 Mar; 77(3):687-93. PubMed ID: 12600862
[TBL] [Abstract][Full Text] [Related]
19. Non-fasting reference intervals for the Abbott IMx homocysteine and AxSYM plasma folate assays: influence of the methylenetetrahydrofolate reductase 677 C-->T mutation on homocysteine.
Donnelly JG; Isotalo PA
Ann Clin Biochem; 2000 May; 37 ( Pt 3)():390-8. PubMed ID: 10817256
[TBL] [Abstract][Full Text] [Related]
20. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages.
Nelen WL; Blom HJ; Thomas CM; Steegers EA; Boers GH; Eskes TK
J Nutr; 1998 Aug; 128(8):1336-41. PubMed ID: 9687553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
